Guiding Stem Cell Differentiation into Oligodendrocytes

合集下载

Morality of Stem Cells

Morality of Stem Cells

– The proposed NIH research will not create or clone human embryos.
– The fertilized eggs are used with permission of the parents who would otherwise discard them.
Morality of Stem Cells
Stem Cells
Definition of stem cells
– Stem cells are “pluripotent” cells that can produce many different kinds of cells. A fertilized egg is “omnipotent”, i.e. can produce all cells.
Importance of Stem Cells
Studies of human embryonic stem cells will lead to major advances in human biology
– Embryonic stem cell research will provide critical insights into mechanisms of cell differentiation, growth, and death.
– The facts that embryos will die anyway and that many people would benefit from the therapies do not justify killing embryos. The end does not justify the means.

人牙周膜干细胞的初步鉴定及体外成骨诱导

人牙周膜干细胞的初步鉴定及体外成骨诱导

万方数据甄蕾,等.人牙周膜干细胞的初步鉴定及体外成骨诱导ZHENLei.etaLHu眦nPeriodontalLigamentStemCellsDifferentiationintoOsteoblasts/nv/tro・319・RNA提取试剂盒、一步法RT.PCR试剂盒(Tiangen公司。

北京)。

1.2方法1.2.1牙周膜细胞原代培养收集临床12一18岁因正畸需要而拔除的牙周健康、无龋的新鲜前磨牙,PBS洗3次,刮取根中l,3牙周膜组织,采用酶解组织块法培养,每隔3d换液.直至细胞从组织块周围游出。

细胞生长达80%汇合时传代。

1.2.2有限稀释法克隆化培养纯化PDLSCs取对数生长期的第1代细胞。

以1~2个/孔的密度接种于96孔板,常规培养7。

14d,至出现细胞克隆(细胞数≥50为判定标准)后扩大培养。

1.2.3PDLSCs的初步鉴定分别取第2代克隆形成细胞进行爬片。

采用SP法检测波形蛋白和角蛋白的表达。

同时利用兀TC荧光标记二抗检测STRO..1和CDl46的表达。

1.2.4体外诱导分化取第2代对数生长期的克隆形成细胞。

按5xllY个/mL接种于24孔板中,待细胞进入对数生长期后弃去原培养液。

PBS洗3遍,换诱导液(10mmol/LB.甘油磷酸钠、10{mol/L地塞米松、50I.Lg/mL维生素C)培养21d。

对照组细胞常规培养。

1.2.5成骨性能的鉴定1.2.5.1茜素红S染色观察钙结节形成人PDLSCs诱导培养21d后弃去培养液,4%多聚甲醛固定30min后饱和茜素红S溶液染色10min,观察钙结节形成情况。

1.2.5.2定性的细胞ALP活性检测人PDLSCs诱导培养21d后弃去培养液。

按ALP检测试剂盒说明书规范操作。

光学显微镜下观察染色情况。

1-2.5.3免疫细胞化学检测BSP、I型胶原表达人PDLSCs诱导培养21d后常规SP法检测BSP、I型胶原蛋白表达情况。

1.2.5.4RT-PCR检测ALP、BSPmRNA表达收集诱导培养21d后的人PDLSCs.。

核苷酸抗代谢物名词解释

核苷酸抗代谢物名词解释

核苷酸抗代谢物1. 介绍核苷酸抗代谢物是一类具有重要生物学功能的化合物,它们在细胞内起着调节代谢过程的关键作用。

核苷酸抗代谢物包括多种化合物,如腺苷、鸟苷、尿苷等。

核苷酸抗代谢物在细胞内通过与核酸相关的生化反应发挥作用。

它们可以通过调节核糖核酸(RNA)和脱氧核糖核酸(DNA)的合成和降解来影响基因表达和遗传信息传递。

它们还参与能量代谢、信号传导、细胞增殖和分化等生命活动过程。

2. 功能2.1 调节基因表达核苷酸抗代谢物可以通过影响RNA和DNA的合成来调节基因表达。

腺苷可以通过激活腺苷酸环化酶(adenylyl cyclase)增加环磷腺苷酸(cAMP)水平,进而激活蛋白激酶A(protein kinase A),从而调节转录因子的活性,影响基因的转录。

2.2 能量代谢核苷酸抗代谢物在能量代谢过程中起着重要作用。

腺苷三磷酸(ATP)是细胞内的主要能量储存分子,它可以通过水解释放出能量供细胞使用。

另外,核苷酸抗代谢物还参与糖原合成、糖解和脂肪酸合成等能量代谢途径。

2.3 信号传导核苷酸抗代谢物还参与细胞内外的信号传导过程。

腺苷和鸟苷可以通过结合细胞表面的腺苷酸受体来调节细胞内的信号传导通路。

这些信号传导通路可以影响细胞的增殖、分化、凋亡等生命活动。

3. 相关疾病核苷酸抗代谢物在多种疾病的发生和发展中起着重要作用。

一些遗传性代谢病与核苷酸抗代谢物的异常有关。

丙氨酰-tRNA合成酶缺乏症是一种由核苷酸抗代谢物异常引起的遗传性代谢疾病,患者体内的丙氨酰-tRNA合成酶活性降低,导致蛋白质合成受到影响。

核苷酸抗代谢物还与一些常见疾病的发生和发展相关。

肿瘤细胞通常具有增强的能量需求和异常的代谢特征,核苷酸抗代谢物在肿瘤细胞中扮演着重要角色。

核苷酸抗代谢物可能成为治疗肿瘤的潜在靶点。

4. 药物开发基于对核苷酸抗代谢物功能的理解,科学家们已经开发出一系列与其相关的药物。

这些药物可以通过调节核苷酸抗代谢物水平来治疗相关疾病。

Rho激酶抑制剂Y27632促进人诱导多能干细胞来源原始神经上皮细胞向多巴胺能神经前体细胞的转化

Rho激酶抑制剂Y27632促进人诱导多能干细胞来源原始神经上皮细胞向多巴胺能神经前体细胞的转化

参考文献:[1]Virani SS,Alonso A,Aparicio HJ,et al.Heart disease and strokestatistics-2021update:a report from the American heart association [J ].Circulation,2021,143(8):e254-743.[2]李天伦,张中,赵蓓,等.急性心肌梗死患者血浆白细胞介素22水平与冠状动脉病变程度和预后的关系[J ].海军军医大学学报,2022,43(4):398-405.[3]Yeh KC,Lee CJ,Song JS,et al.Protective effect of CXCR4antagonist DBPR807against ischemia-reperfusion injury in a rat and porcine model of myocardial infarction:potential adjunctive therapy for percutaneous coronary intervention [J ].Int J Mol Sci,2022,23(19):11730.[4]Zhou ML,Yu YF,Luo XX,et al.Myocardial ischemia-reperfusioninjury:therapeutics from a mitochondria-centric perspective [J ].I/R+CCC I/R+CCC+DSMPSOI/R图7秋水仙碱通过激活AMPK 逆转I/R 手术导致的小鼠心功能下降和心脏损伤Fig.7Colchicine reverses reduced cardiac function and cardiac damage in mice induced by I/R by activating AMPK.A :Representative M-mode ultrasound images of the mice in each group.B -D :Quantitative analysis of the LVEF,LVFS and HR (n =4).E :Representative TTC staining images of the mice in each group.F -H :Quantitative analysis of the infarct area and serum cTnT and LDH levels (n =4).*P <0.05vs SO group;#P <0.05vs I/R group;&P <0.05vs I/R+colchicine group.B CEF ADG H I /RS O I /R+C C C I /R +C CC +D SM P L V E F (%)#*&100.090.080.070.060.050.040.0I /RS O I /R +CC CI /R +C C C +D SM P L V F S (%)SO I/RI/R+CCC I/R+CCC+DSMP60.050.040.030.020.010.00.0H R (B P M )500.0400.0300.0200.0100.00.0I /RS O I /R +CC C I /R +C C C +D SM P I /RS O I /R +C C C I /R +C CC +D SM P I /RS O I /R +C C C I /R +C C C +D SM P I /RS O I /R+C C C I /R +C CC +D SM P I n f a r c a r e a (%)70.060.050.040.030.020.010.00.0L D H i n s e r u m (U /L )1600.01400.01200.01000.0800.0600.0400.0200.00.0c T n T i n s e r u m (p g /m L )450.0400.0350.0300.0250.0200.0150.0100.050.00.0#*&#*&#*&#*&J South Med Univ,2024,44(2):226-235··234Cardiology,2021,146(6):781-92.[5]Chen MX,Li XP,Yang H,et al.Hype or hope:Vagus nerve stimulation against acute myocardial ischemia-reperfusion injury [J].Trends Cardiovasc Med,2020,30(8):481-8.[6]Liu X,Xu L,Wu J,et al.Down-regulation of SIK2expression alleviates myocardial ischemia-reperfusion injury in rats by inhibiting autophagy through the mTOR-ULK1signaling pathway [J].J South Med Univ,2022,42(7):1082-8.[7]Lu CH,Guo X,He XH,et al.Cardioprotective effects of sinomenine in myocardial ischemia/reperfusion injury in a rat model[J].Saudi Pharm J,2022,30(6):669-78.[8]Cadenas S.ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection[J].Free Radic Biol Med, 2018,117:76-89.[9]Maximilian Buja L.Mitochondria in ischemic heart disease[J].Adv Exp Med Biol,2017,982:127-40.[10]Peoples JN,Saraf A,Ghazal N,et al.Mitochondrial dysfunction and oxidative stress in heart disease[J].Exp Mol Med,2019,51(12):1-13.[11]Zou RJ,Shi WT,Qiu JX,et al.Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis[J].Cardiovasc Diabetol,2022,21(1): 106.[12]Tong DC,Wilson AM,Layland J.Colchicine in cardiovascular disease:an ancient drug with modern tricks[J].Heart,2016,102(13):995-1002.[13]Elshafei MN,El-Bardissy A,Khalil A,et al.Colchicine use might be associated with lower mortality in COVID-19patients:a meta-analysis[J].Eur J Clin Invest,2021,51(9):e13645.[14]Deftereos SG,Beerkens FJ,Shah B,et al.Colchicine in cardio-vascular disease:In-depth review[J].Circulation,2022,145(1):61-78.[15]Wang LR,Shan YL,Chen L,et al.Colchicine protects rat skeletal muscle from ischemia/reperfusion injury by suppressing oxidative stress and inflammation[J].Iran J Basic Med Sci,2016,19(6):670-5.[16]Tang YJ,Shi CY,Qin YY,et work pharmacology-based investigation and experimental exploration of the antiapoptotic mechanism of colchicine on myocardial ischemia reperfusion injury [J].Front Pharmacol,2021,12:804030.[17]李晨霏,樊迪,杨政,等.AMPK在心肌纤维化相关疾病中的作用及机制研究进展[J].解放军医学杂志,2021,46(12):1239-44.[18]胡淼,童旭辉,黄杰,等.基于铁死亡探讨AMPK抗小鼠脑缺血/再灌注损伤的作用及机制[J].华中科技大学学报:医学版,2021,50(4):418-23.[19]Zhang Y,Wang Y,Xu JN,et al.Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/ mitophagy and activating the AMPK-OPA1signaling pathways[J].J Pineal Res,2019,66(2):e12542.[20]曾菲,李强,曾昪,等.氢溴酸加兰他敏介导AMPKα1/Nrf2/HO-1通路对大鼠心肌缺血再灌注损伤的保护作用[J].四川大学学报:医学版,2020,51(3):337-43.[21]Wang Y,Viollet B,Terkeltaub R,et al.AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages[J].Ann Rheum Dis,2016,75(1): 286-94.[22]Lu YY,Chen YC,Kao YH,et al.Colchicine modulates calcium homeostasis and electrical property of HL-1cells[J].J Cell MolMed,2016,20(6):1182-90.[23]Liu HQ,Mo HQ,Yang CB,et al.A novel function of ATF3in suppression of ferroptosis in mouse heart suffered ischemia/reperfusion[J].Free Radic Biol Med,2022,189:122-35.[24]Akodad M,Fauconnier J,Sicard P,et al.Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure ina mouse model[J].Int J Cardiol,2017,240:347-53.[25]Yu HL,Liu Q,Chen GD,et al.SIRT3-AMPK signaling pathway as a protective target in endothelial dysfunction of early sepsis[J].IntImmunopharmacol,2022,106:108600.[26]Lv DY,Luo MH,Cheng Z,et al.Tubeimoside I ameliorates myocardial ischemia-reperfusion injury through SIRT3-dependentregulation of oxidative stress and apoptosis[J].Oxid Med CellLongev,2021,2021:5577019.[27]Xiang M,Lu YD,Xin LY,et al.Role of oxidative stress in reperfusion following myocardial iIschemia and Its treatments[J].Oxid Med Cell Longev,2021,2021:6614009.[28]Yue HH,Liang WT,Zhan YJ,et al.Colchicine:emerging therapeutic effects on atrial fibrillation by alleviating myocardial fibrosis in a ratmodel[J].Biomedecine Pharmacother,2022,154:113573.[29]Yang MY,Lv H,Liu Q,et al.Colchicine alleviates cholesterol crystal-induced endothelial cell pyroptosis through activating AMPK/SIRT1pathway[J].Oxid Med Cell Longev,2020,2020:9173530.[30]Xin T,Lu CZ.SirT3activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury[J].Aging,2020,12(16):16224-37.[31]Feng LF,Ren JL,Li YF,et al.Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway[J].Free Radic Res,2019,53(1):82-93.[32]Tian L,Cao WJ,Yue RJ,et al.Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats withmyocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1alpha signaling pathway[J].J Pharmacol Sci,2019,139(4):352-60.[33]吴志林,朱轶.右美托咪定通过Trx1/AMPK通路减轻心肌缺血再灌注损伤中的氧化应激[J].华中科技大学学报:医学版,2020,49(4):404-7.[34]Wu SN,Zou MH.AMPK,mitochondrial function,and cardio-vascular disease[J].Int J Mol Sci,2020,21(14):4987.[35]秦秀男,秦溱,冉珂,等.七氟醚预处理通过线粒体NAD+-SIRT3通路减轻大鼠心肌缺血再灌注损伤[J].中南大学学报:医学版,2022,47(8):1108-19.[36]韦亚忠,薛晓梅,何斌.活性氧介导心肌缺血再灌注损伤的研究进展[J].上海交通大学学报:医学版,2021,41(6):826-9.[37]Paradies G,Paradies V,Ruggiero FM,et al.Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury:implications for pharmacological cardiopro-tection[J].Am J Physiol Heart Circ Physiol,2018,315(5):H1341-52.[38]Brenner D,Mak TW.Mitochondrial cell death effectors[J].Curr Opin Cell Biol,2009,21(6):871-7.(编辑:经媛) J South Med Univ,2024,44(2):226-235··235帕金森病(PD )是一种进行性神经退行性疾病,是60岁以上人群中第2常见的神经退行性疾病,其主要原因是黑质致密部(SNc )多巴胺能(DA )神经元的死亡和含α-突触核蛋白的路易体的形成[1]。

Cell differentiation

Cell differentiation

Cell differentiation: 是指个体发育过程中细胞之间在形态、结构功能上逐渐产生稳定性差异,形成不同细胞类群的过程。

特点:稳定性特定条件下可产生去分化和转分化时-空性和细胞分裂相关cell determination:细胞分化命运的决定。

是指在个体发育过程中,细胞在发生可识别的分化特征之前,就已确定了未来的发育命运,只能向特定方向分化的状态。

特点:稳定性Transdifferentiation,:高度分化的动物细胞从一种分化状态(序列)转变为另一种分化状态(序列)的现象。

Dedifferentiation:在某些条件下,分化了的细胞并不稳定,其基因活动模式也可发生可逆性的变化,又回到未分化状态。

Housekeeping gene:指导生成维持细胞生存所必须的最基本的蛋白质,并不参与细胞分化方向的确定。

luxury gene:指导细胞特异蛋白的产生。

这些蛋白和分化细胞的特异性状密切相关,但并不是细胞基本生命活动必不可少的。

影响细胞分化的主要因素有哪些?一、细胞质对细胞分化的影响: 母源效应基因产物的极性分布和胚胎细胞的胞质不对称分裂,决定了细胞分化命运二、胚胎细胞间相互作用: 诱导具有层次性、区域特异性和遗传特异性,协调细胞分化方向三、激素:动物发育过程中的变态发育晚期,按预先决定的分化程序调节分化四、环境因素Stem cell: 存在于个体发育过程中,具有长期(或无限)自我更新能力、并可分化产生某种(或多种)特化细胞的原始细胞。

是个体的生长发育、组织器官的结构和功能的动态平衡,以及其损伤后的再生修复的基础。

干细胞的种类: 按分化潜能分类:全能干细胞多能干细胞专能干细胞来源分类:胚胎干细胞成体干细胞肿瘤干细胞totipotent SC:能形成完整的个体哺乳动物——受精卵和8-细胞期之前的细胞,每一个细胞都是全能干细胞。

能形成个体中所有类型的细胞以及起营养作用的胎盘等胚胎外的组织pluripotent SC囊胚中的内细胞团,每一个细胞都能形成个体中所有类型的细胞但不能产生胎盘和其他一些发育时期的支持组织不能形成完整的个体multipotent SC只能分化形成功能上密切相关的一类细胞stem cell niche干细胞通常栖息在体内一个固定的、稳态的、安全的、血供丰富的微环境中,该区域被称为干细胞巢。

小鼠胚胎干细胞体外诱导分化成GABA能神经元

小鼠胚胎干细胞体外诱导分化成GABA能神经元

小鼠胚胎干细胞体外诱导分化成GABA能神经元目的探讨小鼠胚胎干细胞在体外培养向GABA能神经元定向诱导分化的可能性。

方法将小鼠胚胎干细胞以“无血清”方法培养,用DMEM/F12、N2、B27及NT4作为诱导分化剂定向诱导分化,分化好的细胞利用免疫荧光技术、流式细胞技术和RT-PCR鉴定。

结果在胚胎干细胞诱导分化成神经元后期,免疫荧光显示有GABA能神经元存在;RT-PCR结果证实有GABA能神经元正确分化的重要调控基因Viaat、Gad1和Gad2基因表达;流式细胞仪计数结果显示GABA阳性细胞约占总细胞数的(11.49±6.86)%。

结论小鼠胚胎干细胞经体外培养可以定向诱导分化成GABA能神经元,可作为神经移植的新来源。

[Abstract] ObjectiveTo investigate the possibilities of in vitro culture and differentiation of mouse embryonic stem cell to GABAergic neurons. MethodsMouse embryonic stem cells were cultured and induced into GABAergic neurons in serum-free cultural condition. Immunofluorescence,reverse transcription polymerase chain reaction(RT-PCR) and flow cytometer assay were used to identify the properties of the differentiated cells. ResultsIn the later period of differentiation of embryonic stem cells into neurons,immunofluorescence showed that GABAergic neurons existed,RT-PCR results confirmed the important regulatory genes Viaat,Gad1 and Gad2 gene expression due to the correct differentiation of GABAergic neurons and flow cytometry analysis showed the GABA-positive cells accounted for about(11.49±6.86)% of the total cell number. ConclusionMouse embryonic stem cells can be induced into GABAergic neurons in vitro in serum-free cultural condition,providing a new source of nerve graft.[Key words]Embryonic stem cell; Induce; Differentiate; GABA干细胞移植治疗中枢神经系统疾病的研究方兴未艾,且取得了一定成果,但由于其多取材于胚脑的神经干细胞,为日后临床应用埋下了伦理道德问题之患,并且受到供体来源短缺的限制[1]。

以肿瘤坏死因子α转基因小鼠为类风湿关节炎模型的研究进展

以肿瘤坏死因子α转基因小鼠为类风湿关节炎模型的研究进展王腾腾;徐浩;王拥军;施杞;梁倩倩【摘要】Rheumatoid arthritis (RA) was recognized as a chronic and autoimmune disease.The overexpression of tumor necrosis factor alpha (TNF-α) was of great significance in the pathogenesis of RA and mediated the levels of various inflammatory factors.At present,anti-TNF agents were widely used for the treatment of RA in clinic.The genetically modified mice,overexpressing human TNF-α,could appear pathological manifestations being similar to RA with slow onset,high incidence rate and stablc occurrence.Therefore,TNF transgenic (TNF-Tg) mouse model was significant in the study,generally applied to the curative and mechanism researches of RA,especially some remarkable and fruitful studies over lymphatic vessels.In this study,we summarized the pathophysiological characteristics of the mouse model based on the current research status.%类风湿关节炎(Rheumatoid Arthritis,RA)是一种慢性自身免疫疾病,肿瘤坏死因子α(Tumor Necrosis Factor,TNF-a)过表达在本病的发病过程中起到重要的作用,并介导了多种炎症因子的表达.目前抗TNF药物已广泛应用于RA临床.过表达人TNF-a的转基因小鼠可出现类似RA的病理表现:起病缓慢、发病率高、模型稳定.因此,TNF转基因(TNF-Tg)小鼠模型在RA研究中具有重要的意义,现已广泛应用于RA的诊疗技术和病理机制研究,尤其是淋巴管功能的研究,并取得一系列成果.本文针对该模型小鼠的生理病理特征、研究进展进行综述.【期刊名称】《世界科学技术-中医药现代化》【年(卷),期】2016(018)011【总页数】5页(P1869-1873)【关键词】肿瘤坏死因子α;转基因小鼠;类风湿关节炎;淋巴【作者】王腾腾;徐浩;王拥军;施杞;梁倩倩【作者单位】上海中医药大学附属龙华医院上海200032;上海中医药大学脊柱病研究所上海200032;上海中医药大学附属龙华医院上海200032;上海中医药大学脊柱病研究所上海200032;上海中医药大学附属龙华医院上海200032;上海中医药大学脊柱病研究所上海200032;上海中医药大学康复医学院上海200120;上海中医药大学附属龙华医院上海200032;上海中医药大学脊柱病研究所上海200032;上海中医药大学附属龙华医院上海200032;上海中医药大学脊柱病研究所上海200032【正文语种】中文【中图分类】R274RA是一种以对称性、多发性关节炎为主要临床表现的慢性免疫性疾病,主要的病理改变为:滑膜的增生、炎性因子的浸润、软骨及骨组织的破坏等[1]。

Stemcelltherapy将重新定义医学界

Stemcelltherapy将重新定义医学界Stem Cell Therapy: Redefining the Medical Field Introduction:In recent years, healthcare has witnessed tremendous advancements in regenerative medicine. One groundbreaking innovation that holds immense promise is stem cell therapy. Stem cell therapy employs the use of stem cells to repair damaged tissues and regenerate new cells, offering a potentially revolutionary approach to treating a wide range of medical conditions. This article delves into the potential of stem cell therapy to redefine the medical field, exploring its applications, current challenges, and future prospects.The Power of Stem Cells:Stem cells possess a unique ability to differentiate into various cell types, making them the building blocks of the human body. Through their remarkable regenerative potential, stem cells hold the key to potentially curing previously untreatable diseases. They can be harvested from various sources, including embryos, umbilical cords, and adult tissues, making them accessible for therapeutic use. With the ability to differentiate into specialized cells such as neurons, heart cells, and pancreatic cells, stem cells offer endless possibilities for medical interventions.Application in Disease Treatment:Stem cell therapy has already shown significant promise in multiple medical fields. In neurodegenerative diseases like Parkinson's and Alzheimer's, stem cells can potentially replace damaged neurons and restore brain function. Similarly, in spinal cord injuries, stem cells may provide a means to repair and regenerate damaged nerve tissue, potentially leading to restored mobility for patients. Stem cell therapy also holds the potential torevolutionize the treatment of cardiovascular diseases, diabetes, and even certain types of cancer.Cardiovascular diseases, such as heart failure, can greatly benefit from stem cell therapy. By injecting stem cells into damaged areas of the heart, researchers have observed improved heart function and reduced scar tissue formation. This breakthrough offers hope for millions of individuals suffering from cardiovascular conditions worldwide.Diabetes, a chronic disease affecting millions of people globally, may also find newfound hope through stem cell therapy. By differentiating stem cells into pancreatic beta cells, which produce insulin, scientists are exploring the potential for curing diabetes by replacing dysfunctional or destroyed cells within the pancreas. This approach could transform the lives of patients, dramatically altering the management and control of diabetes.Challenges and Ethical Considerations:Though stem cell therapy holds immense potential, it is not without challenges and ethical considerations. One major challenge lies in the ability to control and direct the differentiation of stem cells into desired cell types. Researchers continue to refine their methodologies and techniques to ensure reliable and predictable outcomes. Additionally, the safety and long-term effects of stem cell therapy require extensive research and clinical trials to establish efficacy and mitigate potential risks.Ethical considerations surrounding the use of embryonic stem cells also pose challenges. The extraction of embryonic stem cells often involves the destruction of embryos, and this raises ethical concerns for some. However, alternative sources of stem cells, such as adult tissues and umbilical cords, offer a more ethically acceptable solution for those who oppose the use of embryonic stem cells.Future Prospects and Conclusion:Stem cell therapy has the potential to redefine the medical field by unlocking endless possibilities for disease treatment and regenerative medicine. As scientists continue to delve deeper into understanding the mechanisms of stem cell differentiation and harness their full potential, the future looks promising. Advances in stem cell research may pave the way for personalized medicine, where therapies are tailored to individual patients based on their unique needs. With ongoing research, clinical trials, and collaborations, stem cell therapy is set to revolutionize healthcare, offering hope for those suffering from currently incurable diseases.In conclusion, stem cell therapy has the potential to redefine the medical field by offering a new paradigm for disease treatment and regeneration. Though challenges and ethical considerations exist, the power of stem cells to repair and regenerate holds immense promise for countless patients worldwide. As research advances and scientific breakthroughs unfold, stem cell therapy may soon become a cornerstone of modern medicine, bringing us closer to a future where previously untreatable conditions become curable.。

骨髓基质干细胞向心肌细胞分化的研究进展


Marrow Stromal Stem
Cells into Cardiomyocytes and Its Clinical Applications
GUAN Chun—yan, GAO Hang
(Cardiology
Department,The First
Affiliated
Hospital
ofLiaoning Medical College,Jinzhou 中图分类号:Q21
物¨2t1”。5-Aza为一抗肿瘤药物,早在1985年就有人
cells,HSCs)和BMSCs,前者可分
化成所有类型的造血细胞旧J,后者则是一类非造血细 胞的多能干细胞,属成体干细胞,可贴壁生长,形态类 似成纤维细胞。近年发现,BMSCs不仅具有体外高度 扩增、多向分化潜能,还可被移植和抑制移植物抗宿主 病等特性,所以又被称为骨髓间质干细胞。
cells into native
myocardial fibers・anatomic
forfunctionalimprovements[J].JThorac
590.
Cardiovase
Surg,2002,124(3):584-
[15]Beltrami
tent
AP,Barheehi L,Torella D。et a1.Adult cardiac stem cells
增后的细胞能保持原有细胞正常的核型和端粒酶活 性。虽然BMSCs约有20%的细胞处于静止G0期,但 其足以维持增殖分化,满足移植需要。BMSCs不仅有 一定的自我更新能力,可分化为骨、软骨和脂肪等多种
类型的基质细胞071,在一定外界环境条件下还能实现 跨系统分化(transdifferentiation)。大量实验表明,BM—

细胞分化的重要性英语作文

细胞分化的重要性英语作文English:Cell differentiation is crucial for the development and functioning of multicellular organisms. It is the process by which stem cells become specialized into different cell types with specific functions. This specialization allows cells to carry out specific tasks within the body, contributing to the overall health and functioning of the organism. Without cell differentiation, an organism would not be able to develop properly and would not be able to maintain homeostasis. In addition, cell differentiation plays a critical role in tissue repair and regeneration. When tissues are damaged, specialized cells are needed to replace the damaged ones and restore normal function. Furthermore, cell differentiation is essential for embryonic development, as it determines the formation of various organs and tissues in the growing organism. Overall, cell differentiation is vital for the proper development, functioning, and maintenance of multicellular organisms.Translated content:细胞分化对多细胞生物的发育和功能至关重要。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

COMMUNICATIONGuiding Stem Cell Differentiation into Oligodendrocytes Using Graphene-Nanofi ber Hybrid ScaffoldsS hreyas S hah ,P erry T. Y in ,T hiers M. U ehara ,S y-Tsong Dean C hueng ,L etao Y ang ,a nd K i-Bum L ee *of the CNS, while eliminating the potential adverse or variable side-effects from growth factors and viral gene vectors, wouldbe highly benefi cial. [ 8]H erein, we report the use of a graphene-based nanomaterial for the design of hybrid nanofi brous scaffolds to guide NSC dif-ferentiation into oligodendrocytes ( F igure 1). Graphene-based nanomaterials, such as graphene oxide (GO), have recently gained considerable interest for tissue engineering applications due to their favorable chemical, electrical and mechanical prop-erties. [ 9] Besides serving as a highly elastic and fl exible struc-tural reinforcement, substrates coated with GO have been dem-onstrated to promote the growth and differentiation of variousstem cell lines, including induced PSCs, MSCs and NSCs.[ 10 ] Based on these considerations, we demonstrate the use of GO as an effective coating material in combination with electro-spun nanofi bers for the selective differentiation of NSCs into oligodendrocytes. By varying the amount of GO coating on the nanofi bers, we observed a GO concentration-dependent change in the expression of key neural markers, wherein coating with a higher concentration of GO was seen to promote differentia-tion into mature oligodendrocytes. Further investigation into the role of GO-coating on the nanofi brous scaffolds showed the overexpression of a number of key integrin-related intracellular signaling molecules that are known to promote oligodendrocyte differentiation in normal development. E lectrospun nanofi ber scaffolds exhibit several key prop-erties that are advantageous for neural tissue engineering, including a high degree of porosity, high surface-to-volume ratio, and a relatively close structural mimic of the native extra-cellular matrix (ECM).[ 11 ] From the wide array of polymeric materials available, we used polycaprolactone (PCL) to generate our nanofi brous scaffolds. PCL is a biodegradable and biocom-patible polyester approved by the FDA for use in the human body as a drug delivery device and suture, and is also widelyused for neural tissue engineering.[ 12 ] In our studies, PCL was electrospun onto a metallic collector and then transferred to glass substrates for cell culture using a medical grade adhe-sive. Nanofi bers with an average diameter of 200–300 nm were generated, which is a fi ber size range that has been reported to be favorable for oligodendrocyte culture, potentially due tothe close morphological resemblance to axons [ 13 ]( F igure 2a ).Thin-layered graphene oxide (GO) was then synthesized and dispersed in deionized water (Figure S1, Supporting Infor-mation). The hydrophobic PCL nanofi bers were exposed to oxygen plasma to render the surface hydrophilic (Figure S2, Supporting Information). The GO was then deposited on the PCL nanofi ber surface, thus allowing for the effi cient and uni-form coating of the PCL nanofi ber surface with GO, as seenS . Shah, S.-T. D. Chueng, L. Yang, Prof. K.-B. LeeD epartment of Chemistry and Chemical Biology, Rutgers The State University of New Jersey P iscataway ,N J 08854 ,U SA E-mail: k blee@P . T. Yin, Prof. K.-B. LeeD epartment of Biomedical EngineeringR utgers, State University of New Jersey P iscataway ,N J 08854 ,U SAT . M. UeharaP hysics Institute of São Carlos University of São PauloCP 369 São Carlos, S ão Paulo 13566 ,B razilDOI: 10.1002/adma.201400523D amage to the central nervous system (CNS) from degenera-tive diseases or traumatic injuries is particularly devastating due the limited regenerative capabilities of the CNS. Among the current approaches, stem-cell-based regenerative medicine has shown great promise in achieving signifi cant functional recovery by taking advantage of the self-renewal and differentia-tion capabilities of stem cells, which include pluripotent stem cells (PSCs), mesenchymal stem cells (MSCs) and neural stemcells (NSCs).[ 1] However, the low survival rate upon transplan-tation has been a longstanding barrier for scientists and clini-cians to overcome.[ 2] To this end, numerous types of natural and synthetic biomaterial scaffolds have been developed, the two main classes being hydrogels and nanofi bers, in an attempt to mimic the cellular microenvironment, support cellulargrowth and improve cellular viability.[ 3] Nevertheless, designing scaffolds with defi ned properties to selectively guide stem cell differentiation towards a specifi c neural cell lineage is still an ongoing challenge.F or CNS regeneration, the selective differentiation of NSCs into either neurons or oligodendrocytes (as opposed to astro-cytes) is highly desirable.[ 4] A number of approaches have been employed to guide differentiation into neurons, including genetic modifi cations, growth factors, cytokines, substratetopography and even nanomaterials.[ 5] However, oligoden-drocyte differentiation has proven to be much more elusive, resulting in only a small percentage of the differentiated cellpopulation.[ 6] The primary approach to guide oligodendro-cyte differentiation has focused on either developing culture media containing a combination of growth factors or the forced expression of key oligodendrocyte-promoting transcription fac-tors via viral gene transfection. [ 7] However, developing a bio-materials-approach to achieve effi cient differentiation of NSCsinto mature oligodendrocytes, which are the myelinating cellsC O M M U N I C A T I O NF igure 1. S chematic diagram depicting the fabrication and application of graphene-nanofi ber hybrid scaffolds. Polymeric nanofi bers (composed of polycaprolactone) generated using electrospinning were subsequently coated with graphene oxide (GO) and seeded with neural stem cells (NSCs). NSCs cultured on the graphene-nanofi ber hybrid scaffolds show enhanced differentiation into oligodendrocyte lineage cells.F igure 2. M orphology of nanofi brous scaffolds and cultured NSCs on the scaffolds. a,b) FE-SEM images of PCL nanofi bers (a) and PCL nanofi bers coated with GO using 1.0 mg/mL GO solution (b). Scale bars: 2 µm. c,d) FE-SEM of differentiated NSCs cultured on PCL nanofi ber scaffolds (c) and graphene-nanofi ber hybrid scaffolds (d) after six days of culture. The cells are pseudo-colored blue for contrast. The differentiated cells on the graphene-nanofi ber hybrid scaffolds (d) show a clear morphological difference in terms of process extension compared with the nanofi ber scaffolds alone (c). Scale bars: 10 µm.COMMUNICATIONwith fi eld emission scanning electron microscopy (FE-SEM) (Figure 2 b and Figure S3, Supporting Information) and helium ion microscopy (Figure S4, Supporting Information).F or the culture of NSCs, the scaffolds were then coated with laminin, a well-established ECM protein which is essen-tial for the adhesion, growth and differentiation of NSCs. [ 14 ]Green fl uorescent protein-labeled adult rat hippocampal NSCs (purchased from Millipore) were then seeded onto the scaf-folds and the morphology was monitored using fl uorescence microscopy. After six days of culture, a signifi cant difference in the cellular morphology was evident on GO-coated nanofi bers compared to the nanofi bers alone (Figure S5, Supporting Infor-mation). FE-SEM shows cell attachment on these surfaces in greater detail, wherein the cells on the GO-coated nanofi bers display extensive branching of cell processes (Figure 2 c ,d and Figure S6, Supporting Information). This type of extensive pro-cess extension is a characteristic attribute reported to distin-guish oligodendrocytes from other neural cells. [ 15 ] This differ-ence in cellular morphology provides evidence for the potential ability of our hybrid scaffolds to enhance NSC differentiationinto oligodendrocytes.T o systematically investigate the effect of GO-coating on NSC differentiation, we generated hybrid scaffolds with varying amounts of GO-coating. Solutions containing three different concentrations of GO (0.1, 0.5 and 1.0 mg/mL) were depos-ited on oxygen plasma-treated PCL nanofi bers. The degree of coating using the various GO concentrations was then observed using FE-SEM ( F igure 3 a ). GO-coating of PCL with 0.1 mg/mL, indicated as PCL-GO (0.1), shows the clear pres-ence of GO compared with the PCL nanofi bers alone, with uniform coating on the surface of individual fi bers. In con-trast, PCL-GO (0.5) and PCL-GO (1.0) exhibit a much greater extent of GO attachment on the nanofi brous surface, showing a high degree of GO coating and connectivity between fi bers. This was confi rmed quantitatively using Raman spectroscopy,where the characteristic peaks of the D band (ca. 1350 cm −1)and G band (ca. 1600 cm −1 ) indicate the presence of GO. Com-parison of the Raman intensity of these peaks further supportsF igure 3. E ffect of concentration-dependent GO-coating on NSC differentiation. a) FE-SEM images of PCL nanofi bers coated with GO solutions ofvarying concentrations: 0.0 mg/mL [PCL], 0.1 mg/mL [PCL-GO (0.1)], 0.5 mg/mL [PCL-GO (0.5)] and 1.0 mg/mL [PCL-GO (1.0)]. Scale bars: 1 µm. b) Raman spectroscopy of glass and PCL nanofi bers coated with varying concentrations of GO. c) Quantitative PCR of NSCs grown on various substrates from RNA isolated after six days of culture. The plot shows fold change in gene expression of markers indicative of neurons (TuJ1), astrocytes (GFAP) and oligodendrocytes (MBP), wherein the PCL-GO substrates show the highest expression of MBP. The gene expression is relative to GAPDH, and normalized to the conventional PLL-coated glass control. Student's unpaired t-test was used for evaluating signifi cance (* = p < 0.05, ** = p < 0.01, n.s. = no signifi cance), compared to the PLL-coated glass control (denoted above the bar) or between different substrates.C O M M U N I C A T I O Nthe trend described above in terms of concentration-dependent GO coating on the PCL nanofi ber surfaces (Figure 3 b ). Moreover, the nanofi brous scaffolds at all three concentrations show signifi cantly higher GO content compared with the con-trol glass surfaces coated with the same respective amounts of GO (Figure 3 b ). The higher surface area-to-volume of the nano-fi bers available for GO attachment, in conjunction with the 3D structure of these scaffolds, may attribute to this difference in coating. T hese various PCL-GO substrates were then used to examine the infl uence of GO-coating on modulating NSC differentiation. For comparison, the following control substrates were used: i) PLL-coated glass (conventional substrate for in vitro neural cultures), ii) PCL nanofi bers alone, and iii) GO-coated glass (at the abovementioned three GO concentrations). All of the sub-strates were coated with laminin to facilitate NSC attachment, and the cells were harvested after six days of culture to compare the gene expression of key neural markers. Quantitative PCR (qPCR) was utilized to compare gene expression of three key markers that are indicative of differentiated NSCs: glial fi bril-lary acidic protein (GFAP; astrocytes), beta-III tubulin (TuJ1; neurons) and myelin basic protein (MBP; mature oligoden-drocytes). First, it is important to note that both the PCL nano-fi bers alone and GO-coated glass (at all three concentrations) individually show enhanced oligodendrocyte gene expression, with about a 2-fold increase in MBP expression (Figure 3 c ). At the same time, TuJ1 shows only about a 1.3-fold increase and GFAP shows about a 0.5-fold decrease in expression, which indicates a stronger preference for differentiation towards oli-godendrocytes rather than neurons and astrocytes (Figure 3 c ). While no reports exist for the effect of graphene-based nano-materials on oligodendrocyte differentiation, previous studies have reported that electrospun nanofi bers can act as permissiveculture platforms for oligodendrocyte culture.[ 16 ] S ince each individual component (nanofi bers and GO) dis-played a favorable trend in NSC differentiation towards oligo-dendrocytes, we hypothesized that the combination of GO and nanofi bers in a single scaffold may have a synergistic effect. In the PCL-GO samples, we observed a remarkable trend in gene expression of these neural markers. The nanofi bers coated at the lowest GO concentration (0.1 mg/mL) showed a 6.5-fold increase in MBP, which is much higher than the expression on PCL nanofi bers alone and GO-coated glass controls (Figure 3 c ). Interestingly, this enhancement in MBP expression was even more pronounced when the concentration of GO was further increased, wherein the cells on PCL-GO (0.5) showed an 8.9-fold increase and PCL-GO (1.0) showed a 9.9-fold increase in MBP expression (Figure 3 c ). Based on the data, there is no statisti-cally signifi cant difference in MBP expression on the PCL-GO (0.5) and PCL-GO (1.0), indicating the saturation of GO on the PCL nanofi ber surface. The overall increase in MBP expression of the cells grown on the PCL-GO substrates points to the role of GO in the observed result, in which the 3D PCL nanotopo-graphy serves to increase the amount of GO coating and the con-sequent surface interface in contact with the NSCs compared with the traditional 2D surfaces. In addition, the simultaneous decrease in GFAP expression and relatively small increase in TuJ1 expression provides further evidence that the hybrid scaffold promotes selective NSC differentiation, with a strong preference towards oligodendrocyte lineage cells (Figure 3 c ). To explore the potential of these hybrid scaffolds as a culture platform for oligodendrocyte differentiation, we elected to use PCL-GO (1.0) for all subsequent experiments (termed PCL-GO hereafter). In regard to biocompatibility, NSCs grown on these scaffolds show excellent survival, as found with cell viability assays (Figure S7, Supporting Information).W e next sought to further characterize the degree of differ-entiation into oligodendrocytes by examining the expression of well-established oligodendrocyte markers at the genetic- and cellular-level. After six days of culture, the cells grown on PCL-GO were immunostained for the early marker Olig2 and the mature marker MBP ( F igure 4a ,b). The immunostained cells show extensive expression of both the nuclear-localized Olig2 and the cytosolic MBP. A similar expression was also observed for the oligodendrocyte-specifi c surface markers O4 (early) and GalC (mature) (Figure S8, Supporting Informa-tion). Expression of these protein markers confi rms the suc-cessful NSC differentiation into oligodendrocytes. The degree of differentiation was further quantifi ed by determining the percentage of cells expressing Olig2 and MBP on the various substrates (Figure 4 c ,d). While the conventional PLL-coated glass substrates showed only about 9% of the cells expressing Olig2, both the PCL only and GO-coated glass substrates showed about 16% Olig2-expressing cells (Figure 4 c ). On the other hand, the PCL-GO substrate displayed about 33% of the cells expressing Olig2, which is signifi cantly higher than all other conditions (Figure 4 c ). A similar trend was also observed for MBP expression, wherein 26% of the cells on PCL-GO were positive for MBP, which corroborates the gene expression results shown earlier (Figure 3 c ). Comparison of the percentage of cells stained for TuJ1 (neurons) and GFAP (astrocytes) fur-ther supports the selective differentiation into oligodendrocytes, with PCL-GO displaying a signifi cant decrease in GFAP-posi-tive cells and a minor increase in the number of TuJ1-positive cells (Figure S9, Supporting Information). Given the diffi culty in achieving the spontaneous differentiation of stem cells into oligodendrocytes, our unique graphene-nanofi ber hybrid scaf-folds exhibit a signifi cant enhancement in oligodendrocyte formation. T o further confi rm that the hybrid scaffolds promote oli-godendrocyte differentiation, we evaluated changes in gene expression for a variety of well-known early and mature oli-godendrocyte-specifi c markers. qPCR was carried out for detecting the gene expression of: i) early markers including 2’,3’-cyclic-nucleotide 3’-phosphodiesterase (CNP), platelet-derived growth factor receptor alpha (PDGFR α), Olig1 and Olig2, and ii) mature markers including proteolipid protein (PLP), MBP, myelin-associated glycoprotein (MAG), myelin oli-godendrocyte glycoprotein (MOG), adenomatous polyposis coli (APC), glutathione S-transferase-pi (GST-π) and galactocerebro-side (GalC). For all genes of interest, NSCs on PCL-GO exhib-ited the strongest level of expression compared with all other control substrates (Figure 4 e ,f and Figure S10, Supporting Information). Interestingly, several of the known genes indica-tive of myelinating oligodendrocytes also showed a substantial increase in gene expression. For instance, MAG and MOG, which are glycoproteins reported to be crucial during the myeli-nation process in the CNS, [ 15 ] were seen to have a 17-fold andCOMMUNICATION19-fold increase in gene expression, respectively (Figure 4f). Taken together, these results confirm that NSCs cultured on PCL-GO substrates exhibit a strong preference towards oligo-dendrocyte differentiation.T hese hybrid scaffolds provide a unique microenvironment that was found to be permissive to oligodendrocyte formation. Nevertheless, how the extracellular cues from these hybrid scaf-folds modulate intracellular signaling pathways to control this selective differentiation remains to be explored. Numerous studies report the importance of stem cell–extracellular matrix interactions in directing oligodendrocyte differentiation. [ 17 ] These interactions have been observed to modulate intracel-lular signaling pathways, primarily through the activation of integrin receptors found on the cellular membrane. Integrin-mediated signaling has been found to be especially important for facilitating fundamental oligodendrocyte processes, suchF igure 4. E nhancement in oligodendrocyte differentiation on PCL-GO. a,b) Fluorescence image of NSCs grown on PCL-GO after six days of culture, stained for the early oligodendrocyte marker Olig2 (a) and the mature oligodendrocyte marker MBP (b). Scale bars: 20 µm. c,d) Quantitative com-parison on various substrates of the percentage of cells expressing Olig2 (c) and MBP (d). The graphs show the mean ± s.e.m, n= 3, comparison by ANOVA – * = p< 0.01. e,f) Quantitative PCR analysis was used to assess the gene expression of early oligodendrocyte markers including CNP, PDGFR, Olig1 and Olig2 (e), and mature oligodendrocyte markers including PLP, MBP, MAG and MOG (f). The gene expression is relative to GAPDH, and normalized to the conventional PLL-coated glass control. A student's unpaired t-test was used for evaluating the signifi cance (* = p< 0.05, ** = p< 0.01), compared to the PLL-coated glass control.C O M M U N I C A T I O NF igure 5. E xpression of integrin-related signaling proteins on nanofi brous scaffolds. a) Schematic diagram depicting the integrin signaling proteins involved in oligodendrocyte differentiation and development. b) Quantitative PCR analysis was used to assess the gene expression of the integrin signaling proteins FAK, Akt, ILK and Fyn. The gene expression is relative to GAPDH, and normalized to the conventional PLL-coated glass control. A student’s unpaired t-test was used for evaluating the signifi cance (* = p < 0.05, ** = p < 0.01), compared to the PLL-coated glass control. c) Confocal images of NSCs grown on various substrates (PLL-coated glass, PCL only, GO-coated glass and PCL-GO) after six days of culture, co-stained for Olig2 (purple) and FAK (orange). Scale bar: 20 µm.COMMUNICATIONas survival, differentiation and myelination. [ 18 ]Culminating evidence from previous reports suggests the role of several key signaling proteins downstream of integrins in regulating oligodendrocyte differentiation and development, including focal adhesion kinase (FAK ), Akt, integrin-linked kinase (ILK )and Fyn kinase (Fyn) [ 18 ]( F igure 5 a ). Therefore, we investigatedwhether oligodendrocyte differentiation-related signal transduc-tion is promoted in NSCs cultured on PCL-GO.A mong the various cell-signaling proteins, we examined the expression of FAK, Akt, ILK and Fyn, which have been found to mediate cytoskeletal remodeling and process extension during oligodendrocyte development. Moreover, disruption of each of these proteins has been reported to cause a variety of developmental defects, including reduced process exten-sion, aberrant myelin formation and attenuated expression ofmyelin proteins. [ 19 ] We found that NSCs cultured on the GO-coated surfaces enhanced the gene expression of all of thesefactors (Figure 5 b ). These signaling molecules exhibited the same trend in expression, wherein the GO-coated glass showed higher expression than PCL, and PCL-GO showed the strongest level of expression with a 2.6-fold increase in FAK and about a 1.7-fold increase in Akt, ILK and Fyn (Figure 5 b ). Additionally, treating the cells grown on PCL-GO scaffolds with cell sign-aling inhibitors showed a signifi cant decrease in gene expres-sion of mature oligodendrocyte markers, which provides fur-ther evidence for the potential role of such cellular signaling in the observed oligodendrocyte differentiation (Figure S11, Sup-porting Information). Collectively, this data supports the role of GO-coating in the upregulation of these downstream molecules in the integrin signaling pathway and may explain, at least in part, the enhanced oligodendrocyte differentiation of NSCs on our hybrid scaffolds.I n order to further elucidate this correlation, we sought to observe cellular co-localization of markers indicative of both integrin signaling and oligodendrocyte differentiation using confocal microscopy. Dual staining was carried out for: i) Olig2, an oligodendrocyte marker, and ii) FAK, one of the main reg-ulators of integrin-ECM signaling[ 19d ] and found in our study to show the highest expression in cells cultured on PCL-GO. The immunostaining for Olig2 (purple) and FAK (orange) was compared for NSCs cultured on PCL-GO with the other con-trol substrates (Figure 5 c ). As observed earlier, cells grown on PCL-GO showed the strongest intensity and highest number of cells expressing Olig2, with minimal expression on the glass control and moderate expression on PCL and GO. A similar trend was also observed in FAK staining, which corresponds to the gene expression levels shown in Figure 5 b . Since the locali-zation of FAK is in the cytoplasm and Olig2 is in the nucleus, the co-localization of the two markers within the same cell can be easily visualized. Interestingly, the cells expressing FAK also expressed Olig2, a phenomenon that was observed on all sub-strates (Figure 5 c ). Moreover, PCL-GO showed the strongest expression of both markers and the highest number of cells co-expressing FAK and Olig2. Together, our data suggests that the GO-coating on the nanofi ber scaffolds may promote oli-godendrocyte differentiation through specifi c microenviron-mental interactions which activate integrin-related intracellular signaling.O verall, we have demonstrated the capability of a unique gra-phene-nanofi ber hybrid scaffold to provide instructive physicalcues that lead to the selective differentiation of neural stemcells into mature oligodendrocytes, without introducing dif-ferentiation inducers in the culture media. The ability to selec-tively guide stem cell differentiation by merely changing the properties of an underlying biomaterial scaffold is a valuable approach for tissue engineering, which can help complement or potentially eliminate the use of exogenous differentiation inducers such as viral gene vectors, growth factors and small molecule drugs. Moreover, our hybrid scaffold is exceptional in that it combines the well-established properties of nanofi bers and graphene-based nanomaterials. For instance, nanofi bers have been shown to provide ideal topography for fabricating nerve guidance conduits, directing neurite outgrowth and pro-moting axonal regeneration. [ 3a ,11 ] On the other hand, graphene-based nanomaterials provide permissive surfaces for proteinand cell adhesion, as well as high conductivity to mediate elec-trical stimulation for supporting neuronal electrophysiology. [ 20 ]In turn, a hybrid scaffold which combines the morphological features of nanofi bers and the unique surface properties of gra-phene-based nanomaterials in a single culture platform, can be highly benefi cial. We envision that such a platform can serve as a powerful tool for developing future therapies for CNS-related diseases and injuries.S upporting InformationSupporting Information is available from the Wiley Online Library or from the author.A cknowled gementsK .-B.L. acknowledges fi nancial support from the NIH Director’s Innovator Award [1DP20D006462–01], National Institute of Biomedical Imaging and Bioengineering of the NIH [1R21NS085569–01], the N.J. Commission on Spinal Cord grant [09–3085-SCR-E-0], and the Rutgers Faculty Research Grant Program. S.S. acknowledges NSF DGE 0801620, Integrative Graduate Education and Research Traineeship (IGERT) on the Integrated Science and Engineering of Stem Cells. T.M.U. acknowledges fi nancial support from FAPESP (Research Foundation from São Paulo State) and Prof. Valtencir Zucolotto (University of São Paulo, Brazil). We acknowledge NIH grant S10RR025424 to Dr. Nilgun Tumer for a confocal microscope. The authors acknowledge NSF grant DMR 1126468 to Prof. Torgny Gustafsson and assistance from Dr. Samir Shubeita for helium ion microscope imaging.[1] a ) J . W. M cDonald ,X . Z. L iu ,Y . Q u ,S . L iu ,S . K. M ickey ,D . T uretsky ,D . I. G ottlieb ,D . W. C hoi ,N at. Med. 1999,5,1410 ;b ) S . P luchino ,A . Q uattrini ,E . B rambilla ,A . G ritti ,G . S alani ,G . D ina ,R . G alli ,U . D el Carro ,S . A madio ,A . B ergami ,R . F urlan ,G . C omi ,A . L. V escovi ,G . M artino ,N ature 2003,422,688 ;c ) L . R. Z hao ,W . M. D uan ,M . R eyes ,C . D. K eene ,C . M. V erfaillie ,W . C. L ow ,E xp. Neurol. 2002,174,11 .[2] T . S hindo ,Y . M atsumoto ,Q . W ang ,N . K awai ,T . T amiya ,S . N agao , J . Med. Invest. 2006,53,42 .[3] a ) H . C ao ,T . L iu ,S . Y . C hew ,A dv. Drug Delivery Rev. 2009,61,1055 ;b ) G . O rive ,E . A nitua ,J . L. P edraz ,D . F. E merich ,N at. Rev. Neurosci. 2009,10,682 .Received: F ebruary 1, 2014Revised: F ebruary 17, 2014 Published online: M arch 26, 2014C O M M U N I C A T I O N[4] a ) H . S. K eirstead ,G . N istor ,G . B ernal ,M . T otoiu ,F . C loutier ,K . S harp ,O . S teward ,J . Neurosci. 2005,25,4694 ;b ) M . A bematsu ,K . T sujimura ,M . Y amano ,M . S aito ,K . K ohno ,J . K ohyama ,M . N amihira ,S . K omiya ,K . N akashima ,J . Clin. Invest. 2010,120,3255 .[5] a ) S . Y . P ark ,J . P ark ,S . H . S im ,M . G. S ung ,K . S. K im ,B . H . H ong ,S . H ong ,A dv. Mater. 2011,23,H 263 ;b ) S . S hah ,A . S olanki ,P . K. S asmal ,K .-B. L ee ,J . Am. Chem. Soc. 2013,135,15682 ;c ) A . S olanki ,S . S hah ,P . T. Y in ,K .-B. L ee ,S ci. Rep. 2013,3,1553 ;d ) J . T akahashi ,T . D. P almer ,F . H . G age ,J . Neurobiol. 1999,38,65 ;e ) A . S olanki ,S . S hah ,K . A. M emoli ,S . Y . P ark ,S . H ong ,K .-B. L ee ,S mall 2010,6,2509 .[6] F . S her ,R . R ößler ,N . B rouwer ,V . B alasubramaniyan ,E . B oddeke ,S . C opray ,S TEM CELLS 2008,26,2875 ;DOI: 10.1634/stemcells.2008-0121 .[7] F . S her ,V . B alasubramaniyan ,E . B oddeke ,S . C opray ,C urr. Opin. Neurol. 2008,21,607 .[8] C . Z hao ,A . T an ,G . P astorin ,H . K. H o ,B iotechnol. Adv. 2013,31,654 .[9] a ) Y . Z hu ,S . M urali ,W . C ai ,X . L i ,J . W. S uk ,J . R. P otts ,R . S. R uoff , A dv. Mater. 2010,22,3906 ;b ) T . H . K im ,K . B. L ee ,J . W. C hoi , B iomaterials 2013,34,8660 .[10] a ) G . Y . C hen ,D . W. P ang ,S . M. H wang ,H . Y . T uan ,Y . C. H u , B iomaterials 2012,33,418 ;b ) W . C. L ee ,C . H . L im ,H . S hi ,L . A. T ang ,Y . W ang ,C . T. L im ,K . P. L oh ,A CS Nano 2011,5,7334 ;c ) A . S olanki ,S .-T. D. Chueng ,P . T. Y in ,R . K appera ,M . C hhowalla ,K .-B. L ee ,A dv. Mater. 2013,25,5477 .[11] J . X ie ,M . R. M acEwan ,A . G. S chwartz ,Y . X ia ,N anoscale 2010,2,35 .[12] A . C ipitria ,A . S kelton ,T . R. D argaville ,P . D. D alton ,D . W. H utmacher ,J . Mater. Chem. 2011,21,9419 .[13] G . T. C hristopherson ,H . S ong ,H . Q. M ao ,B iomaterials 2009,30,556 .[14] Q . S hen ,Y . W ang ,E . K okovay ,G . L in ,S . M. C huang ,S . K. G oderie ,B . R oysam ,S . T emple ,C ell Stem Cell 2008,3,289 .[15] N . B aumann ,D . P ham-Dinh ,P hysiol. Rev. 2001,81,871 .[16]a ) S . L ee ,M . K. L each ,S . A. R edmond ,S . Y . C hong ,S . H . M ellon ,S . J. T uck ,Z . Q. F eng ,J . M. C orey ,J . R. C han ,N at. Methods 2012,9,917 ;b ) D . R. N isbet ,L . M. Y u ,T . Z ahir ,J . S. F orsythe ,M . S. S hoichet ,J . Biomater. Sci., Polym. Ed. 2008,19,623 .[17] H . C olognato ,I . D. T zvetanova ,D ev. Neurobiol. 2011,71,924 .[18] R . W. O'Meara ,J . P. M ichalski ,R . K othary ,J . Signal Transduction 2011,2011,354091 .[19]a ) R . W. O'Meara ,J . P. M ichalski ,C . A nderson ,K . B hanot ,P . R ippstein ,R . K othary ,J . Neurosci. 2013,33,9781 ;b )D .J.O sterhout ,A .W olven ,R .M.W olf ,M .D.R esh ,M .V.C hao ,J . Cell Biol. 1999,145,1209 ;c ) C . S. B arros ,T . N guyen ,K . S. S pencer ,A . N ishiyama ,H . C olognato ,U . M uller ,D evelopment 2009,136,2717 ;d ) A . D. F orrest ,H . E. B eggs ,L . F. R eichardt ,J . L. D upree ,R . J. C olello ,B . F uss ,J . Neurosci. Res. 2009,87,3456 .[20]Y . Z hang ,T . R. N ayak ,H . H ong ,W . C ai ,N anoscale 2012,4,3833 .。

相关文档
最新文档